Sites of Extra Hepatic Metabolism, Part III: Kidney

Handbook of Drug Metabolism, Second Edition

Volumn , Issue , 2008, Pages 299-326

  Lash, Lawrence H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953799885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420076486-15     Document Type: Chapter

References (131)

1. Walker LA, Valtin H. Biological importance of nephron heterogeneity. Annu Rev Physiol 1982; 44:203-219.
2. Guder WG, Ross BD. Enzyme distribution along the nephron. Kidney Int 1984; 26:101-111.
3. Lash LH. Use of freshly isolated and primary cultures of proximal tubular and distal tubular cells from rat kidney. In: Zalups RK, Lash LH, eds. Methods in Renal Toxicology. Boca Raton, FL: CRC Press, 1996:189-215.
4. Lash LH. In vitro methods of assessing renal damage. Toxicol Pathol 1998; 26:33-42.
5. Chung SD, Alavi N, Livingston D, Hiller S, Taub M. Characterization of primary rabbit kidney cultures that express proximal tubule functions in a hormonally defined medium. J Cell Biol 1982; 95:118-126.
6. Taub ML, Yang IS, Wang Y. Primary rabbit kidney proximal tubule cell cultures maintain differentiated functions when cultured in a hormonally defined serum-free medium. In Vitro Cell Dev Biol 1989; 25:770-775.
7. Aleo MD, Taub ML, Nickerson PA, Kostyniak PJ. Primary cultures of rabbit renal proximal tubule cells: I. Growth and biochemical characteristics. In Vitro Cell Dev Biol 1989; 25:776-783.
8. Nowak G, Schnellmann RG. Improved culture conditions stimulate gluconeogenesis in primary cultures of renal proximal tubule cells. Am J Physiol 1995; 268:C1053-C1061.
9. Blumenthal SS, Lewand DL, Buday MA, Mandel NS, Mandel GS, Kleinman JG. Effect of pH on growth of mouse renal cortical tubule cells in primary culture. Am J Physiol 1989; 257:C419-C426.
10. Boogaard PJ, Zoeteweij JP, van Berkel TJC, van’t Noordende JM, Mulder GJ, Nagelkerke JF. Primary culture of proximal tubular cells from normal rat kidney as an in vitro model to study mechanisms of nephrotoxicity: toxicity of nephrotoxicants at low concentrations during prolonged exposure. Biochem Pharmacol 1990; 39:1335-1345.
11. Chen TC, Curthoys NP, Lagenaur CF, Puschett JB. Characterization of primary cell cultures derived from rat renal proximal tubules. In Vitro Cell Dev Biol 1989; 25:714-722.
12. Elliget KA, Trump BF. Primary cultures of normal rat kidney proximal tubule epithelial cells for studies of renal cell injury. In Vitro Cell Dev Biol 1991; 27A:739-748.
13. Hatzinger PB, Stevens JL. Rat kidney proximal tubule cells in defined medium: the roles of cholera toxin, extracellular calcium and serum in cell growth and expression of g-glutamyltransferase. In Vitro Cell Dev Biol 1989; 25:205-212.
14. Lash LH, Tokarz JJ, Pegouske DM. Susceptibility of primary cultures of proximal tubular and distal tubular cells from rat kidney to chemically induced toxicity. Toxicology 1995; 103:85-103.
15. Miller JH. Restricted growth of rat kidney proximal tubule cells cultured in serumsupplemented and defined media. J Cell Physiol 1986; 129:264-272.
16. Rosenberg MR, Michalopoulos G. Kidney proximal tubular cells isolated by collagenase perfusion grow in defined media in the absence of growth factors. J Cell Physiol 1987; 131:107-113.
17. Sakhrani LM, Badie-Dezfooly B, Trizna W, Mikhail N, Lowe AG, Taub M, Fine LG. Transport and metabolism of glucose by renal proximal tubular cells in primary culture. Am J Physiol 1984; 246:F757-F764.
18. Taub ML, Yang IS, Wang Y. Primary rabbit kidney proximal tubule cell cultures maintain differentiated functions when cultured in a hormonally defined serum-free medium. In Vitro Cell Dev Biol 1989; 25:770-775.
19. Toutain H, Vauclin-Jacques N, Fillastre J-P, Morin J-P. Biochemical, functional, and morphological characterization of a primary culture of rabbit proximal tubule cells. Exp Cell Res 1991; 194:9-18.
20. Pizzonia JH, Gesek FA, Kennedy SM, Coutermarsh BA, Bacskal BJ, Friedman PA. Immunomagnetic separation, primary culture, and characterization of cortical thick ascending limb plus distal convoluted tubule cells from mouse kidney. In Vitro Cell Dev Biol 1991; 27A:409-416.
21. Scott DM, Zierold K, Kinne R. Development of differentiated characteristics in cultured kidney (thick ascending loop of Henle) cells. Exp Cell Res 1986; 162:521-529.
22. Courjault-Gautier F, Chevalier J, Abbou CC, Chopin DK, Toutain HJ. Consecutive use of hormonally defined serum-free media to establish highly differentiated human renal proximal tubule cells in primary culture. J Am Soc Nephrol 1995; 5:1949-1963.
23. Cummings BS, Lash LH. Metabolism and toxicity of trichloroethylene and S-(1, 2- dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells. Toxicol Sci 2000; 53:458-466.
24. Cummings BS, Lasker JM, Lash LH. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J Pharmacol Exp Ther 2000; 293:677-685.
25. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 1984; 25:383-390.
26. Rodilla V, Miles AT, Jenner W, Hawksworth GM. Exposure of cultured human proximal tubular cells to cadmium, mercury, zinc and bismuth: toxicity and metallothionein induction. Chem Biol Interact 1998; 115:71-83.
27. Trifillis AL, Regec AL, Trump BF. Isolation, culture and characterization of human renal tubular cells. J Urol 1985; 133:324-329.
28. Van Der Biest I, Nouwen EJ, Van Dromme SA, De Broe ME. Characterization of pure proximal and heterogeneous distal human tubular cells in culture. Kidney Int 1994; 45:85-94.
29. Lash LH. Principles and methods for renal toxicology. In: Hayes AW, ed. Principles and Methods in Toxicology. 5th ed. Boca Raton, FL: CRC Press, 2008:1508-1540.
30. Berkhin EB, Humphreys MH. Regulation of renal tubular secretion of organic compounds. Kidney Int 2001; 59:17-30.
31. Burckhardt G, Bahn A, Wolff NA. Molecular physiology of renal p-aminohippurate secretion. News Physiol Sci 2001; 16:114-118.
32. Hagenbuch B, Peier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family:phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 2004; 447:653-665.
33. Inui K-I, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int 2000; 58:944-958.
34. Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 2004; 447:666-676.
35. Lee W, Kim RB. Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol 2004; 44:137-166.
36. Robertson EE, Rankin GO. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion. Pharmacol Ther 2006; 109:399-412.
37. Russel FGM, Masereeuw R, van Aubel RAMH. Molecular aspects of renal anionic drug transport. Annu Rev Physiol 2002; 64:563-594.
38. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84:987-1049.
39. Lock EA, Reed DJ. Renal xenobiotic metabolism. In: Goldstein RS, ed. Comprehensive Series in Toxicology, Vol. 7: Kidney Toxicology. Oxford: Elsevier, 1997:77-97.
40. Lohr JW, Willsky GR, Acara A. Renal drug metabolism. Pharmacol Rev 1998; 50:107-141.
41. Jones DP, Orrenius S, Jakobson SW. Cytochrome P-450-linked monooxygenase systems in the kidney. In: Gram TE, ed. Extrahepatic Metabolism of Drugs and Other Foreign Compounds. New York: Spectrum Publications, 1980:123-158.
42. Ronis MJJ, Huang J, Longo V, Tindberg N, Ingelman-Sundberg M, Badger TM. Expression and distribution of cytochrome P450 enzymes in male rat kidney: effects of ethanol, acetone and dietary conditions. Biochem Pharmacol 1998; 55:123-129.
43. Lash LH, Fisher JW, Lipscomb JC, Parker JC. Metabolism of Trichloroethylene. Environ Health Perspec 2000; 108(suppl 2):177-200.
44. National Toxicology Program (NTP). Report on Carcinogens, 11th ed., Research Triangle Park, NC: U.S. Department of Heath and Human Services, Public Health Service, National Toxicology Program, 2005.
45. Lash LH, Parker JC, Scott CS. Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspec 2000; 108(suppl 2):225-240.
46. Cummings BS, Parker JC, Lash LH. Cytochrome P450-dependent metabolism of trichloroethylene in rat kidney. Toxicol Sci 2001; 60:11-19.
47. Lash LH, Putt DA, Cai H. Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. Toxicology 2008; 244:56-65.
48. Lash LH, Putt DA, Huang P, Hueni SE, Parker JC. Modulation of hepatic and renal metabolism and toxicity of trichloroethylene and perchloroethylene by alterations in status of cytochrome P450 and glutathione. Toxicology 2007; 235:11-26.
49. Cummings BS, Zangar RC, Novak RF, Lash LH. Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metab Dispos 1999; 27:542-548.
50. Amet Y, Berthou F, Fournier G, Dréano Y, Bardou L, Cledes J, Ménez J-F. Cytochrome P450 4A and 2E1 expression in human kidney microsomes. Biochem Pharmacol 1997; 53:765-771.
51. Hu JJ, Rhoten WB, Yang CS. Mouse renal cytochrome P450IIE1: immunocytochemical localization, sex-related differences and regulation by testosterone. Biochem Pharmacol 1990; 40:2597-2602.
52. Bebri K, Boobis AR, Davies DS, Edward RJ. Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissue. Biochem Pharmacol 1995; 50:2047-2056.
53. Schuetz EG, Schuetz JD, Grogan WM, Naray-Fejes-Toth A, Fejes-Toth G, Raucy J, Guzelian P, Gionela K, Watlington CO. Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch Biochem Biophys 1992; 294:206-217.
54. Guengerich FP. Polymorphism of cytochrome P-450 in humans. Trends Pharmacol Sci 1989; 10:107-109.
55. Haener BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, Hall SD. Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 1996; 50:52-59.
56. Ito O, Alonso-Galicia M, Hopp KA, Roman RJ. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol 1998; 274:F395-F404.
57. Okita JR, Johnson SB, Castle PJ, Dezellem SC, Okita RT. Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney. Drug Metab Dispos 1997; 25:1008-1012.
58. Stec DE, Flasch A, Roman RJ, White JA. Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice. Am J Physiol 2003; 284:F95-F102.
59. Cashman JR, Zhang J. Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 2006; 46:65-100.
60. Ziegler DM. Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 1993; 33:179-199.
61. Dolphin CT, Beckett DT, Janmohamed A, Cullingford TE, Smith RL, Shephard EA, Phillips IR. The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein. J Biol Chem 1998; 273:30599-30607.
62. Hines RN, Cashman JR, Philpot RM, Williams DE, Ziegler DM. The mammalian flavincontaining monooxygenases: molecular characterization and regulation of expression. Toxicol Appl Pharmacol 1994; 125:1-6.
63. Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. Human hepatic flavincontaining monooxygenase 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 2002; 51:236-243.
64. Ripp SL, Itagak IK, Philpot, RM, Elfarra AA. Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metab Dispos 1999; 27:46-52.
65. Krause RJ, Lash LH, Elfarra AA. Human kidney flavin-containing monooxygenases and their potential roles in cysteine S-conjugate metabolism and nephrotoxicity. J Pharmacol Exp Ther 2003; 304:185-191.
66. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 2006; 21:357-374.
67. Sausen PJ, Elfarra AA. Cysteine conjugate S-oxidase: characterization of a novel enzymatic activity in rat hepatic and renal microsomes. J Biol Chem 1990; 265:6139-6145.
68. Sausen PJ, Elfarra AA. Reactivity of cysteine S-conjugates sulfoxides: formation of S-[1- chloro-2-(S-glutathionyl)vinyl]-L-cysteine sulfoxide by the reaction of S-(1, 2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. Chem Res Toxicol 1991; 4:655-660.
69. Sausen PJ, Duescher RJ, Elfarra AA. Further characterization and purification of the flavindependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol Pharmacol 1993; 43:388-396.
70. Elfarra AA, Krause RJ. S-(1, 2, 2-Trichlorovinyl)-L-cysteine sulfoxide, a reactive metabolite of S-(1, 2, 2-trichlorovinyl)-L-cysteine formed in rat liver and kidney microsomes, is a potent nephrotoxicant. J Pharmacol Exp Ther 2007; 321:1095-1101.
71. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, Elfarra AA. Roles of cysteine conjugate b-lyase and S-oxidase in nephrotoxicity: studies with S-(1, 2-dichlorovinyl)-L-cysteine and S-(1, 2- dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Ther 1994; 269:374-383.
72. Lash LH, Putt DA, Hueni SE, Krause RJ, Elfarra AA. Roles of necrosis, apoptosis, and mitochondrial dysfunction in S-(1, 2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells. J Pharmacol Exp Ther 2003; 305:1163-1172.
73. Hao C-M, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 2007; 71:1105-1115.
74. Nasrallah R, Clark J, Hébert RL. Prostaglandins in the kidney: developments since Y2K. Clin Sci 2007; 113:297-311.
75. Schlondorff D, Zanger R, Satriano JA, Folkert, VW, Eveloff J. Prostaglandin synthesis by isolated cells from the outer medulla and from the thick ascending loop of Henle of rabbit kidney. J Pharmacol Exp Ther 1982; 223:120-124.
76. Bonventre JV, Nemenoff R. Renal tubular arachidonic acid metabolism. Kidney Int 1991; 39:438-449.
77. Zenser TV, Davis BB. Enzyme systems involved in the formation of reactive metabolites in the renal medulla: cooxidation via prostaglandin H synthase. Fundam Appl Toxicol 1984; 4:922-929.
78. Zenser TV, Cohen SM, Mattammal MB, Wise RW, Rapp NS, Davis BB. Prostaglandin hydroperoxidase catalyzed activation of certain N-substituted aryl renal and bladder carcinogens. Environ Health Perspec 1983; 49:33-41.
79. Wise RW, Zenser TV, Rice JR, Davis BB. Peroxidatic metabolism of benzidine by intact tissue: a prostaglandin H synthase-mediated process. Carcinogenesis 1986; 7:111-115.
80. Zenser TV, Mattammal MB, Davis BB. Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J Pharmacol Exp Ther 1979; 211:460-464.
81. Zenser TV, Mattammal MB, Wise RW, Rice JR, Davis BB. Prostaglandin H synthasecatalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis. J Pharmacol Exp Ther 1983; 227:545-550.
82. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 2005; 15:677-685.
83. Shelby MK, Cherrington NJ, Vansell NR, Klaassen CD. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 2003; 31:326-333.
84. Wells PG, Mackenzie PI, Chowshury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, Ritter JK. Glucuronidation and the UDPglucuronosyltransferases in health and disease. Drug Metab Dispos 2004; 32:281-290.
85. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 2006; 90:5-22.
86. Lindsay J, Wang LL, Li Y, Zhou SF. Structure, function and polymorphism of human cytosolic sulfotransferases. Curr Drug Metab 2008; 9:99-105.
87. Nowel S, Falany CN. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 2006; 25:1673-1678.
88. Rozzel B, Hansson H-A, Guthenberg C, Tahir MK, Mannervik B. Glutathione transferases of classes a, m and p show selective expression in different regions of rat kidney. Xenobiotica 1993; 23:835-849.
89. Cummings BS, Parker JC, Lash LH. Role of cytochrome P450 and glutathione S-transferase a in metabolism and cytotoxicity of trichloroethylene in rat kidney. Biochem Pharmacol 2000; 59:531-543.
90. Board PG, Anders MW. Human glutathione transferase-Zeta. Methods Enzymol 2005; 401:61-77.
91. Board PG, Baker RT, Chelvanayagam G, Jermiin LS. Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J 1997; 328:929-935.
92. Board PG, Chelvanayagam G, Jermiin LS, Tetlow N, Tzeng HF, Anders MW, Blackburn AC. Identification of novel glutathione transferases and polymorphic variants by expressed sequence tag database analysis. Drug Metab Dispos 2001; 29:544-547.
93. Jakobsson P-J, Morgenstern R, Mancini J, Ford-Hutchinson A, Persson B. Common structural features of MAPEG - a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci 1999; 8:689-692.
94. Otieno MA, Baggs RB, Hayes JD, Anders MW. Immunolocalization of microsomal glutathione S-transferases in rat tissues. Drug Metab Dispos 1997; 25:12-20.
95. Lash LH, Lipscomb JC, Putt DA, Parker JC. Glutathione conjugation of trichloroethylene in human liver and kidney: kinetics and individual variation. Drug Metab Dispos 1999; 27:351-359.
96. Lash LH, Qian W, Putt DA, Jacobs K, Elfarra AA, Krause RJ, Parker JC. Glutathione conjugation of trichloroethylene in rats and mice: sex-, species-, and tissue-dependent differences. Drug Metab Dispos 1998; 26:12-19.
97. Lash LH, Xu Y, Elfarra AA, Duescher RJ, Parker JC. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab Dispos 1995; 23:846-853.
98. Hinchman CA, Ballatori N. Glutathione-degrading capacities of liver and kidney in different species. Biochem Pharmacol 1990; 40:1131-1135.
99. Griffith OW, Meister A. Translocation of intracellular glutathione to membrane-bound g-glutamyl transpeptidase as a discrete step in the g-glutamyl cycle: glutathionuria after inhibition of transpeptidase. Proc Natl Acad Sci U S A 1979; 76:268-272.
100. Birner G, Werner M, Rosner E, Mehler C, Dekant W. Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1, 2, 3, 4, 4-pentachlorobutadienyl)-L-cysteine sulfoxide. Chem Res Toxicol 1998; 11:750-757.
101. Wolfgang GHI, Gandolfi AJ, Stevens JL, Brendel K. N-Acetyl S-(1, 2-dichlorovinyl)-Lcysteine produces a similar toxicity to S-(1, 2-dichlorovinyl)-L-cysteine in rabbit renal slices:differential transport and metabolism. Toxicol Appl Pharmacol 1989; 101:205-219.
102. Zhang G, Stevens JL. Transport and activation of S-(1, 2-dichlorovinyl)-L-cysteine and N-acetyl-S-(1, 2-dichlorovinyl)-L-cysteine in rat kidney proximal tubules. Toxicol Appl Pharmacol 1989; 100:51-61.
103. Lash LH, Parker JC. Hepatic and renal toxicities associated with perchloroethylene. Pharmacol Rev 2001; 53:177-208.
104. Yin H, Jones JP, Anders MW. Metabolism of 1-fluoro-1, 1, 2-trichloroethane, 1, 2-dichloro-1, 1-difluoroethane, and 1, 1, 1-trifluoro-2-chloroethane. Chem Res Toxicol 1995; 8:262-268.
105. Cooper AJL, Pinto JT. Cysteine S-conjugate b-lyases. Amino Acids 2006; 30:1-15.
106. Abraham DG, Patel PP, Cooper AJL. Isolation from rat kidney of a cytosolic high molecular weight cysteine-S-conjugate b-lyase with activity toward leukotriene E4. J Biol Chem 1995; 270:180-188.
107. Abraham DG, Thomas RJ, Cooper AJL. Glutamine transaminase K is not a major cysteine S-conjugate b-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role. Mol Pharmacol 1995; 48:855-860.
108. Elfarra AA, Lash LH, Anders MW. Alpha-keto acids stimulate rat renal cysteine conjugate b-lyase activity and potentiate the cytotoxicity of S-(1, 2-dichlorovinyl)-L-cysteine. Mol Pharmacol 1987; 31:208-212.
109. Stevens JL, Robbins JD, Byrd RA. A purified cysteine conjugate b-lyase from rat kidney cytosol: requirement for an a-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K. J Biol Chem 1986; 261:15529-15537.
110. Andreadou I, Menge WMPB, Commandeur JNM, Worthington EA, Vermeulen NPE. Synthesis of novel se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: evaluation of kinetics of b-elimination reactions in rat renal cytosol. J Med Chem 1996; 39:2040-2046.
111. Drieman JC, Thijssen HHW, Struyker-Boudier HAJ. Renal selective N-acetyl-g-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-g-glutamyl sulfamethoxazole. J Pharmacol Exp Ther 1990; 252:1255-1260.
112. Drieman JC, Thijssen HHW, Struyker-Boudier HAJ. Renal selective N-acetyl-L-g-glutamyl prodrugs: studies on the selectivity of some model prodrugs. Br J Pharmacol 1993; 108:204-208.
113. Elfarra AA, Hwang IY. Targeting of 6-mercaptopurine to the kidneys: metabolism and kidneyselectivity of S-(6-purinyl)-L-cysteine analogs in rats. Drug Metab Dispos 1993; 21:841-845.
114. Elfarra AA, Duescher RJ, Hwang IY, Sicuri AR, Nelson JA. Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine. J Pharmacol Exp Ther 1995; 274:1298-1304.
115. Hwang Y, Elfarra AA. Cysteine S-conjugates may act as kidney-selective prodrugs: formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine. J Pharmacol Exp Ther 1989; 251:448-454.
116. Hwang IY, Elfarra AA. Kidney-selective prodrugs of 6-mercaptopurine: biochemical basis of kidney selectivity of S-(6-purinyl)-L-cysteine and metabolism of new analogs in rats. J Pharmacol Exp Ther 1991; 258:171-177.
117. Hwang IY, Elfarra AA. Detection and mechanisms of formation of S-(6-purinyl)glutathione and 6-mercaptopurine in rats given 6-chloropurine. J Pharmacol Exp Ther 1993; 264:41-46.
118. Lash LH, Shivnani A, Mai J, Chinnaiyan P, Krause RJ, Elfarra AA. Renal cellular transport, metabolism and cytotoxicity of S-(6-purinyl)glutathione, a prodrug of 6-mercaptopurine, and analogues. Biochem Pharmacol 1997; 54:1341-1349.
119. Lash LH. Role of glutathione transport processes in kidney function. Toxicol Appl Pharmacol 2005; 204:329-342.
120. Newton JF, Braselton WE, Kuo C-H, Kluwe WM, Gemborys MW, Mudge GH, Hook JB. Metabolism of acetaminophen by the isolated perfused kidney. J Pharmacol Exp Ther 1982; 221:76-79.
121. Duggin GG. Mechanisms in the development of analgesic nephropathy. Kidney Int 1980; 18:553-561.
122. Klos C, Koob M, Kramer C, Dekant W. p-Aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates. Toxicol Appl Pharmacol 1992; 115:98-106.
123. West PR, Harman LS, Josephy PD, Mason RP. Acetaminophen: enzymatic formation of a transient phenoxyl free radical. Biochem Pharmacol 1984; 33:2933-2936.
124. Tune BM. The nephrotoxicity of cephalosporin antibiotics- Structure-activity relationships. Comments Toxicol 1986; 1:145-170.
125. Tune BM, Hsu C-Y. The renal mitochondrial toxicity of cephalosporins: specificity of the effect on anionic substrate uptake. J Pharmacol Exp Ther 1990; 252:65-69.
126. Tune BM, Hsu C-Y. Effects of nephrotoxic b-lactam antibiotics on the mitochondrial metabolism of monocarboxylic substrates. J Pharmacol Exp Ther 1995; 274:194-199.
127. Tune BM, Hsu C-Y. Toxicity of cephalosporins to fatty acid metabolism in rabbit renal cortical mitochondria. Biochem Pharmacol 1995; 49:727-734.
128. Tune BM, Sibley RK, Hsu C-Y. The mitochondrial respiratory toxicity of cephalosporin antibiotics. An inhibitory effect on substrate uptake. J Pharmacol Exp Ther 1988; 245:1054-1059.
129. Tune BM, Fravert D, Hsu C-Y. Oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney: a comparative study of cephaloridine and cephaloglycin. Biochem Pharmacol 1989; 38:795-802.
130. Lash LH, Tokarz JJ, Woods EB. Renal cell type specificity of cephalosporin-induced cytotoxicity in suspensions of isolated proximal tubular and distal tubular cells. Toxicology 1994; 94:97-118.
131. Lash LH, Tokarz JJ. Oxidative stress and cytotoxicity of 4-(2-thienyl)butyric acid in isolated rat renal proximal tubular and distal tubular cells. Toxicology 1995; 103:167-175.